Get 40% Off
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas toolCopy Portfolios

AMETEK To Boost Electron Microscopic Capabilities With Gatan

Published 10/01/2019, 04:44 AM
Updated 07/09/2023, 06:31 AM
ADBE
-
ROP
-
RST
-
AME
-

AMETEK, Inc. (NYSE:AME) is leaving no stone unturned to strengthen capabilities in electron microscopy field backed by strategic acquisitions.

The company’s definitive agreement to acquire Gatan from Roper Technologies (NYSE:ROP) is a testament to its strategy.

Notably, Gatan provides instrumentation and software, which are fully compatible with all brands of electron microscopes. These products are used to improve operation and performance of electron microscopes.

Further, Gatan offers electron microscopy cameras and instrumentation, electron energy filters, software and accessories.

The latest move will expand AMETEK’s product portfolio and enhance customer offerings. We note that Gatan will join the company’s Electronic Instruments Group(EIG) after the completion of the deal.

Growth Opportunities

AMETEK with Gatan’s direct detection technology for electron microscopy is likely to rapidly gain traction in the booming global market for electron microscope.

Per a report from Grand View Research, this particular market is expected to see a CAGR of 7.4% between 2018 and 2025.

According to Market Study Report, the market is anticipated to hit $630 million in 2019, and will witness a CAGR of 8% between 2019 and 2024. Further, the report suggests that the market is expected to reach $1 billion by 2024.

We believe the latest move positions AMETEK well to capitalize on the market prospects.

AMETEK, Inc. Revenue (TTM)

AMETEK, Inc. revenue-ttm | AMETEK, Inc. Quote

Buyout to Aid Growth in EIG Segment

Gatan acquisition is expected to add strength to AMETEK’s EIG segment. It will enhance the company’s specialized offerings in high-end analytical instrumentation field.

Further, solutions from Gatan strive to improve microscopy workflows in specimen preparation, imaging and analysis. All these will aid EIG segment in gaining momentumacross high-end research works in materials and life sciences.

Notably, AMETEK generates major part of its total sales from this segment. In second quarter, 2019, it generated $820.2 million of sales (63.6% of sales) from this segment, reflecting an improvement of 10% from the year-ago quarter.

Consequently, we believe the Gatan buyout decision bodes well for the company’s drive to expand its EIG segment. Moreover, the buyout is likely to drive the top line within this segment.

Zacks Rank & Stocks to Consider

Currently, AMETEK carries a Zacks Rank #3 (Hold).

Investors interested in the broader technology sector can consider some better-ranked stocks like Adobe Systems (NASDAQ:ADBE) and Rosetta Stone (NYSE:RST) . Both the stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term earnings growth rate for Adobe and Rosetta Stone is currently pegged at 16.25% and 12.5%, respectively.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our just-released Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

Download Free Report Now >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Adobe Systems Incorporated (ADBE): Free Stock Analysis Report

Rosetta Stone (RST): Free Stock Analysis Report

Roper Technologies, Inc. (ROP): Free Stock Analysis Report

AMETEK, Inc. (AME): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.